Bevacizumab efficacy in treatment of brain radiation necrosis
Keyword(s):
Radiation therapy (RT) plays an important role in treatment of primary and metastatic CNS tumors and some non-neopiastic conditions (arteriovenous malformations, trigeminal neuralgia). Radiation necrosis (RN) is a common adverse effect of RT. Until recently steroid therapy was used as a main treatment regimen for RN. Mechanisms of RN development are not clear; however, it was shown that vascular endothelial growth factor (VEGF) plays a critical role in its formation. A number of surveys showed efficacy of bevacizumab as an anti-VEGF agent in treatment of RN. Radiation necrosis pathogenesis, diagnostics and treatment are summarized in this review.
2014 ◽
Vol 50
(13)
◽
pp. 2336-2350
◽
2017 ◽
Vol 65
(5)
◽
pp. 1483-1492
◽
2014 ◽
Vol 28
(3)
◽
pp. 428-429
◽
2007 ◽
Vol 357
(4)
◽
pp. 924-930
◽
2000 ◽
Vol 74
(22)
◽
pp. 10699-10706
◽
2013 ◽
Vol 28
(1)
◽
pp. 119-121
◽
2019 ◽